This is particularly important for people with co-existing conditions like type 2 diabetes or heart disease
March 3, 2026: Judge Appoints Leadership Team in Ozempic Vision Loss Lawsuits The federal judge overseeing the NAION MDL has selected a team of lawyers to lead the case
Tancredi D, Cardinali I
The future holds promise, including new medications, expanded indications, and greater affordability, but the rapid evolution of obesity management makes it difficult for organizations who assess benefits annually
Newer medications, including GLP-1 drugs, can help patients successfully lose weight to a lesser degree than bariatric surgery
low-density lipoprotein [LDL] cholesterol, BP and glycaemia), with the magnitude of weight loss generally being associated with greater risk factor reduction